National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations

JAMA Internal Medicine

Volumn 174, Issue 5, 2014, Pages 678-686

  Geller, Andrew I ^a   Shehab, Nadine ^a   Lovegrove, Maribeth C ^a   Kegler, Scott R ^b   Weidenbach, Kelly N ^c   Ryan, Gina J ^d   Budnitz, Daniel S ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL   (United States)

^c Global Health Sector   (United States)

^d MERCER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; EXENDIN 4; GLUCOSE; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; LIRAGLUTIDE; LONG ACTING INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; PRAMLINTIDE; SHORT ACTING INSULIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; DIABETES MELLITUS; EMERGENCY CARE; EMERGENCY WARD; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; INSULIN PUMP; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; PRIORITY JOURNAL;

AGE FACTORS; DATA COLLECTION; DIABETES MELLITUS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MEDICATION ERRORS; PUBLIC HEALTH SURVEILLANCE; SEX FACTORS; UNITED STATES;

EID: 84899861516     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.136     Document Type: Article

References (69)

1. Centers for Disease Control and Prevention. National diabetes fact sheet, 2011. http://www.cdc.gov/diabetes/pubs/pdf/ndfs -2011.pdf. Accessed December 31, 2012.
2. Centers for Disease Control and Prevention. Treating diabetes (insulin and oral medication use). http://www.cdc.gov/diabetes/statistics/treating -national.htm. Accessed December 31, 2012.
3. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36(4):1033-1046.
4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14): 977-986.
5. Neugebauer R, Fireman B, Roy JA, O'Connor PJ. Impact of specific glucose-control strategies on microvascular and macrovascular outcomes in 58,000 adults with type 2 diabetes. Diabetes Care. 2013;36(11):3510-3516.
6. Seaquist ER,MillerME, Bonds DE, et al; ACCORD Investigators. The impact of frequent and unrecognized hypoglycemia on mortality in the ACCORD study. Diabetes Care. 2012;35(2):409-414.
7. Zoungas S, Patel A, Chalmers J, et al; ADVANCE Collaborative Group. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010;363(15):1410-1418.
8. Giordano C. Insulin therapy: unmet needs and new perspectives. Minerva Endocrinol. 2013;38(1):95-102.
9. Ismail-Beigi F, Moghissi E, Tiktin M, Hirsch IB, Inzucchi SE, Genuth S. Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. Ann Intern Med. 2011;154(8):554-559.
10. Laiteerapong N, John PM, Nathan AG, Huang ES. Public health implications of recommendations to individualize glycemic targets in adults with diabetes. Diabetes Care. 2013;36(1):84-89.
11. Schroeder T, Ault K. The NEISS sample (design and implementation) 1997 to present. June 1, 2001. http://www.cpsc.gov//PageFiles/106617/2001d011 -6b6.pdf. Accessed November 11, 2013.
12. JhungMA, Budnitz DS, Mendelsohn AB, Weidenbach KN, Nelson TD, Pollock DA. Evaluation and overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES). Med Care. 2007;45(10 suppl 2):S96-S102.
13. Schiller JS, Lucas JW,Ward BW, Peregoy JA. Summary health statistics for U.S. adults: National Health Interview Survey, 2010. Vital Health Stat 10. 2012;(252):1-207.
14. Centers for Disease Control and Prevention. Distinguishing public health research and public health nonresearch. http://www.cdc.gov/od /science/integrity/docs/cdc-policy-distinguishing -public-health-research- nonresearch.pdf. Published July 29, 2010. Accessed August 5, 2013.
15. National Center for Health Statistics Research Data Center. Publishing guidelines. http://www.cdc.gov/rdc/B6Pubeyond /Pub610.htm. Updated March 15, 2012. Accessed August 5, 2013.
16. US Census Bureau. National Health Interview Survey: CAPI manual for NHIS field representatives. ftp://ftp.cdc.gov/pub/Health-Statistics/NCHS /Survey-Questionnaires/NHIS/2011/frmanual.pdf. Published January 2011. Accessed January 3, 2013.
17. National Center for Health Statistics. 2011 NHIS sample adult questionnaire. ftp://ftp.cdc.gov/pub /Health-Statistics/NCHS/Survey- Questionnaires /NHIS/2011/english/qadult.pdf. Published May 30, 2012. Accessed January 3, 2013.
18. National Center for Health Statistics. 2011 NHIS sample child questionnaire. ftp://ftp.cdc.gov/pub /Health-Statistics/NCHS/Survey- Questionnaires /NHIS/2011/english/qchild.pdf. Published May 30, 2012. Accessed January 3, 2013.
19. National Center for Health Statistics. NHIS Survey Description. 2011 National Health Interview Survey (NHIS) public use data release. ftp://ftp.cdc.gov/pub/health-statistics/nchs/dataset -documentation/nhis/2011/ srvydesc.pdf. Published June 2012. Accessed January 4, 2013.
20. Kish L. Survey Sampling. New York, NY: John Wiley & Sons; 1995.
21. Kegler SR. Applying the compound Poisson process model to the reporting of injury-related mortality rates. Epidemiol Perspect Innov. 2007;4:1. doi:10.1186/1742-5573-4-1.
22. American Diabetes Association. Standards of medical care in diabetes - 2013. Diabetes Care. 2013;36(suppl 1):S11-S66.
23. Quilliam BJ, Simeone JC, Ozbay AB, Kogut SJ. The incidence and costs of hypoglycemia in type 2 diabetes. Am J Manag Care. 2011;17(10):673-680.
24. Lucado J, Paez K, Elixhauser A. Medication-Related Adverse Outcomes in U.S. Hospitals and Emergency Departments, 2008: Statistical Brief #109. Healthcare Cost and Utilization Project Statistical Briefs. Rockville, MD: Agency for Healthcare Research and Quality; 2011.
25. Leonard CE, Haynes K, Localio AR, et al. Diagnostic E-codes for commonly used, narrow therapeutic index medications poorly predict adverse drug events. J Clin Epidemiol. 2008;61(6):561-571.
26. Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention. Diabetes Data & Trends: Data from the National Emergency Department Samples, Agency for Healthcare Research and Quality. http://www.cdc.gov/diabetes/ statistics/emergency -national.htm. Published September 11, 2012. Accessed June 3, 2013.
27. Budnitz DS, Pollock DA,Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA. 2006;296(15):1858-1866.
28. Lipska KJ,Wang Y, Ross JS, et al. National trends in hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999-2010. Presented at: 73rd Scientific Sessions of the American Diabetes Association; June 24, 2013; Chicago, IL.
29. Majumdar SR, Hemmelgarn BR, LinM, McBrien K, Manns BJ, Tonelli M. Hypoglycemia associated with hospitalization and adverse events in older people: population-based cohort study. Diabetes Care. 2013;36(11):3585-3590.
30. The VA/DoD Diabetes MellitusWorking Group. VA/DoD clinical practice guideline for the management of diabetes mellitus. http://www.healthquality.va. gov/diabetes/DM2010 -FUL-v4e.pdf. Published August 1, 2010. Accessed August 4, 2013.
31. Brown AF, Mangione CM, Saliba D, Sarkisian CA. Guidelines for improving the care of the older person with diabetes mellitus. J AmGeriatr Soc. 2003;51(5 suppl guidelines):S265-S280.
32. Qaseem A, Vijan S, Snow V, Cross JT,Weiss KB, Owens DK; Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets: a guidance statement from the American College of Physicians. Ann Intern Med. 2007;147(6):417-422.
33. Aron D, Conlin PR, Hobbs C, Vigersky RA, Pogach L. Individualizing glycemic targets in type 2 diabetes mellitus. Ann Intern Med. 2011;155(5):340-341.
34. Berkowitz SA, Aragon K, Hines J, Seligman H, Lee S, Sarkar U. Do clinical standards for diabetes care address excess risk for hypoglycemia in vulnerable patients? a systematic review. Health Serv Res. 2013;48(4):1299-1310.
35. Garber AJ, Abrahamson MJ, Barzilay JI, et al; American Association of Clinical Endocrinologists. AACE comprehensive diabetes management algorithm 2013. Endocr Pract. 2013;19(2):327-336.
36. Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36(5):1384-1395.
37. Qaseem A, Chou R, Humphrey LL, Shekelle P; for the Clinical Guidelines Committee of the American College of Physicians. Inpatient glycemic control: best practice advice from the Clinical Guidelines Committee of the American College of Physicians. Am J Med Qual. 2013. doi:10.1177/1062860613489339.
38. Raz I, Riddle MC, Rosenstock J, et al. Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum. Diabetes Care. 2013;36(6):1779-1788.
39. Inzucchi SE, Bergenstal RM, Buse JB, et al; American Diabetes Association (ADA); European Association for the Study of Diabetes (EASD). Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364-1379.
40. ABIM Foundation Choosing Wisely Initiative. Choosing Wisely: five things physicians and patients should question. http://www.americangeriatrics.org /health-care-professionals/clinical-practice/clinical -guidelines- recommendations/choosingwisely. Published 2013. Accessed August 26, 2013.
41. Cassel CK, Guest JA. Choosing Wisely: helping physicians and patients make smart decisions about their care. JAMA. 2012;307(17):1801-1802.
42. Lipska KJ, Montori VM. Glucose control in older adults with diabetes mellitus - more harm than good? JAMA Intern Med. 2013;173(14):1306-1307.
43. Bailey CJ, Aschner P, Del Prato S, LaSalle J, Ji L, Matthaei S; Global Partnership for Effective Diabetes Management. Individualized glycaemic targets and pharmacotherapy in type 2 diabetes. Diab Vasc Dis Res. 2013;10(5):397-409.
44. Helmer DA, Sambamoorthi U, Rajan M, Tseng CL, Pogach LM. Individualized, non-age-based glycemic control in elderly veterans with diabetes. Diabetes Care. 2008;31(4):728-731.
45. National Committee for Quality Assurance. NQF #0731, comprehensive diabetes care: hemoglobin A1c (HbA1c) control (<8.0%). http://www.qualityforum.org/QPS/0575. Published December 4, 2009. Accessed September 9, 2013.
46. Pogach L, Aron D. The other side of quality improvement in diabetes for seniors: a proposal for an overtreatment glycemic measure. Arch Intern Med. 2012;172(19):1510-1512.
47. Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med. 2013;368(17):1613-1624.
48. AADE. AADE7 Self-care behaviors. Diabetes Educ. 2008;34(3):445-449.
49. Shrivastava SR, Shrivastava PS, Ramasamy J. Role of self-care in management of diabetes mellitus. J DiabetesMetab Disord. 2013;12(1):14. doi:10.1186/2251-6581-12-14.
50. Moghissi E, Ismail-Beigi F, Devine RC. Hypoglycemia: minimizing its impact in type 2 diabetes. Endocr Pract. 2013;19(3):526-535.
51. Haas L, Maryniuk M, Beck J, et al; 2012 Standards Revision Task Force. National standards for diabetes self-management education and support. Diabetes Care. 2012;35(11):2393-2401.
52. Glogan D, Levitan RD, Brooks DE, Gerkin RD. Unintentional use of mistaken insulin products: a retrospective review of poison center data. J Emerg Med. 2013;45(4):547-553.
53. Spiller HA, Borys DJ, RyanML, Sawyer TS, Wilson BL. Unintentional therapeutic errors involving insulin in the ambulatory setting reported to poison centers. Ann Pharmacother. 2011;45(1):17-22.
54. Grissinger M. Avoiding medication errors with insulin therapy. 2010. http://www.schererclin.com /documents/scherer-avoiding-med-errors.pdf. Accessed August 22, 2013.
55. Institute for Safe Medication Practices. A clinical reminder about the safe use of insulin vials. ISMP Medication Safety Alert! Nurse Advise-ERR. 2013;11(3):1-2. http://www.ismp.org /newsletters/nursing/issues /NurseAdviseERR201303.pdf. Accessed August 21, 2013.
56. Cryer PE; American Diabetes Association. Hypoglycemia in Diabetes: Pathophysiology, Prevalence, and Prevention. 2nd ed. Alexandria, VA: American Diabetes Association; 2013.
57. Frier BM. Hypoglycaemia in the diabetic adult. Baillieres Clin Endocrinol Metab. 1993;7(3):757-777.
58. Khunti K, Fisher H, Paul S, Iqbal M, Davies MJ, Siriwardena AN. Severe hypoglycaemia requiring emergency medical assistance by ambulance services in the East Midlands: a retrospective study. Prim Care Diabetes. 2013;7(2):159-165.
59. Krnacova V, Kubena A, Macek K, Bezdek M, Smahelova A, Vlcek J. Severe hypoglycaemia requiring the assistance of emergency medical services - frequency, causes and symptoms. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2012;156(3):271-277.
60. Parsaik AK, Carter RE, Myers LA, et al. Population-based study of hypoglycemia in patients with type 1 diabetes mellitus requiring emergency medical services. Endocr Pract. 2012;18(6):834-841.
61. Farmer AJ, Brockbank KJ, Keech ML, England EJ, Deakin CD. Incidence and costs of severe hypoglycaemia requiring attendance by the emergency medical services in South Central England. Diabet Med. 2012;29(11):1447-1450.
62. Beuhler MC, Spiller HA, Aleguas A. Demographics and outcome of unintentional insulin overdoses managed by three poison centers. Clin Toxicol (Phila). 2013;51(8):789-793.
63. Cryer PE. Hypoglycemia: still the limiting factor in the glycemic management of diabetes. Endocr Pract. 2008;14(6):750-756.
64. Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care. 1994;17(7):697-703.
65. Cornell S, Dorsey VJ. Diabetes pharmacotherapy in 2012: considerations in medication selection. Postgrad Med. 2012;124(4):84-94.
66. US Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Healthy People 2020 objectiveMPS-5: reduce emergency department (ED) visits for common, preventable adverse events from medications. http://www.healthypeople.gov/2020 /topicsobjectives2020/objectiveslist.aspx? topicId =27#123156. Accessed August 23, 2013.
67. Kern LM, Malhotra S, Barrón Y, et al. Accuracy of electronically reported "meaningful use" clinical quality measures: a cross-sectional study. Ann Intern Med. 2013;158(2):77-83.
68. Pogach L, Aron DC. Sudden acceleration of diabetes quality measures. JAMA. 2011;305(7):709-710.
69. Aron D, Rajan M, Pogach LM. Summary measures of quality of diabetes care: comparison of continuous weighted performance measurement and dichotomous thresholds. Int J Qual Health Care. 2007;19(1):29-36.